DalsnaFinance

Mettler Toledo $MTD

Health Care · Life Sciences Tools & Services · NYSE/NASDAQ

S&P 500 Russell 1000 Ohio
Create a scorecard
$1,634.01
+8.28 (+0.51%)
As of Oct 20, 2026, 7:41 PM EDT · cached
Price history
Loading chart…

Key facts

52-week range (closes)
$1,025.53 – $1,598.03 Lowest close May 13, 2026, highest Oct 13, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
Fiscal year ends
December Fiscal 2025 ended Dec 31, 2025, from SEC filings
In the S&P 500 since
Sep 6, 2016, replacing Tyco International (TYC) · TYC acquired JCI and retained JCI ticker. · All S&P 500 changes

Mettler Toledo (MTD) is trading up at $1,634.01 (+0.51%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Mettler Toledo revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$4.03B$2.01B$0FY2016 revenue: $2.51BFY2016 net income: $384.4M · Net margin 15.3%'16FY2017 revenue: $2.73BFY2017 net income: $376.0M · Net margin 13.8%'17FY2018 revenue: $2.94BFY2018 net income: $512.6M · Net margin 17.5%'18FY2019 revenue: $3.01BFY2019 net income: $561.1M · Net margin 18.6%'19FY2020 revenue: $3.09BFY2020 net income: $602.7M · Net margin 19.5%'20FY2021 revenue: $3.72BFY2021 net income: $769.0M · Net margin 20.7%'21FY2022 revenue: $3.92BFY2022 net income: $872.5M · Net margin 22.3%'22FY2023 revenue: $3.79BFY2023 net income: $788.8M · Net margin 20.8%'23FY2024 revenue: $3.87BFY2024 net income: $863.1M · Net margin 22.3%'24FY2025 revenue: $4.03BFY2025 net income: $869.2M · Net margin 21.6%'250%10%20%30%FY2016 net margin: 15.3%FY2017 net margin: 13.8%FY2018 net margin: 17.5%FY2019 net margin: 18.6%FY2020 net margin: 19.5%FY2021 net margin: 20.7%FY2022 net margin: 22.3%FY2023 net margin: 20.8%FY2024 net margin: 22.3%FY2025 net margin: 21.6%
Mettler Toledo annual financial statements
FY2016Dec 2016FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$2.51B$2.73B$2.94B$3.01B$3.09B$3.72B$3.92B$3.79B$3.87B$4.03B
Growth (year over year)+4.7%+8.6%+7.7%+2.5%+2.5%+20.5%+5.4%−3.4%+2.2%+4.0%
Gross profit$1.44B$1.58B$1.68B$1.74B$1.80B$2.17B$2.31B$2.24B$2.33B$2.39B
Gross margin57.3%57.8%57.4%57.9%58.4%58.4%58.9%59.2%60.1%59.4%
Net income$384.4M$376.0M$512.6M$561.1M$602.7M$769.0M$872.5M$788.8M$863.1M$869.2M
Net margin15.3%13.8%17.5%18.6%19.5%20.7%22.3%20.8%22.3%21.6%
EPS (diluted)$14.22$14.24$19.88$22.47$24.91$32.78$38.41$35.90$40.48$42.05
Balance sheet
Cash and equivalents$158.7M$148.7M$178.1M$207.8M$94.3M$98.6M$96.0M$69.8M$59.4M$66.9M
Total assets$2.17B$2.55B$2.62B$2.79B$2.81B$3.33B$3.49B$3.36B$3.24B$3.71B
Total liabilities$1.73B$2.00B$2.03B$2.37B$2.53B$3.16B$3.47B$3.51B$3.37B$3.74B
Long-term debt$875.1M$960.2M$985.0M$1.24B$1.28B$1.58B$1.91B$1.89B$1.83B$2.09B
Shareholders' equity$434.9M$547.3M$590.1M$420.8M$282.7M$171.4M$24.8M−$149.9M−$126.9M−$23.6M
Cash flow
Operating cash flow$460.8M$516.3M$565.0M$603.5M$724.7M$908.8M$859.1M$965.9M$968.3M$955.8M
Capital expenditure$124.0M$127.4M$142.7M$97.3M$92.5M$107.6M$121.2M$105.3M$103.9M$107.1M
Free cash flow$336.8M$388.9M$422.3M$506.1M$632.2M$801.2M$737.8M$860.6M$864.4M$848.6M
Share buybacks$500.0M$400.0M$475.0M$775.0M$775.0M$1000.0M$1.10B$900.0M$850.0M$800.0M

From Mettler Toledo's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

Mettler Toledo vs the Health Care sector and the S&P 500

Mettler Toledo's latest reported figures next to the median of the other 59 S&P 500 Health Care companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.

Mettler Toledo compared with the median Health Care company and the median S&P 500 company
MeasureMettler ToledoHealth Care (59 other S&P 500 companies)S&P 500 (502 other companies)
Revenue growth, latest fiscal year+4.0%+7.2%+7.0%
Net margin, latest fiscal year21.6%12.9%12.9%
Share price change, 1 year+20.4%+22.8%+7.5%

Mettler Toledo: fiscal year ended December 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, Mettler Toledo included, are the last regular-session prices of October 20, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 59/496, net margin 59/496, 1-year price change 59/488; the reasons below can overlap. 14 are left out of the price figure because our archive holds no comparable close for them. The S&P 500 price figure is the middle company's change, not the index's return.

About Mettler Toledo

Mettler Toledo, stylized in all caps, is a multinational supplier of precision instruments and services. The company focuses on laboratory, industrial, product inspection, and food retailing applications. Its products are used in research, quality control, and manufacturing processes in life sciences, food, chemical, and many other industries. The company's business is geographically diversified, with sales in 2023 derived 41% from North and South America, 27% from Europe, and 32% from Asia and other countries. The company’s global workforce consists of 17,300 employees as of December 31, 2023.

Source: Wikipedia — Mettler Toledo

Headquarters
Columbus, Ohio From SEC filings, Oct 2026

Recent News (12)

More Health Care stocks

Browse all companies →